BIO
Gregg Wagner, Ph.D.
Senior Project Manager, Regulatory and Access
Gregg is Senior Project Manager in Regulatory and Consulting at Parexel where he directs and manages large-scale research projects and regulatory projects.
Work experience
Prior to joining Parexel, Gregg held positions as a Senior Manager of Regulatory Affairs and Senior Scientific Project Manager at StrideBio, Inc., an AAV gene therapy company focused on cardiac and CNS indications. Earlier, he worked as a Senior Study Director at Metabolon, Inc., a contract research organization focused on metabolomics.
Education
Gregg earned his Ph.D. in medical and molecular genetics at Indiana University School of Medicine, where he studied the neuromuscular disease Friedreich’s Ataxia. He completed a postdoctoral fellowship at Duke University, where he discovered and characterized novel metabolite-derived protein modifications.